|
TAF9B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.05724326463042E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.07400763230225E-12 |
| Normal-vs-Stage2 |
5.682800E-03 |
| Normal-vs-Stage3 |
1.042460E-03 |
| Normal-vs-Stage4 |
1.256100E-02 |
| Stage1-vs-Stage2 |
5.504400E-01 |
| Stage1-vs-Stage3 |
2.165600E-01 |
| Stage1-vs-Stage4 |
8.103800E-01 |
| Stage2-vs-Stage3 |
6.967800E-01 |
| Stage2-vs-Stage4 |
8.587000E-01 |
| Stage3-vs-Stage4 |
5.748800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.28883578756722E-12 |
| Normal-vs-AfricanAmerican |
4.79099999994848E-06 |
| Normal-vs-Asian |
3.69560000046398E-07 |
| Caucasian-vs-AfricanAmerican |
3.033000E-01 |
| Caucasian-vs-Asian |
4.356400E-01 |
| AfricanAmerican-vs-Asian |
2.655000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-16 |
| Normal-vs-Female |
1.312330E-02 |
| Male-vs-Female |
1.628390E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.4690000005313E-07 |
| Normal-vs-Extreme_Weight |
5.48927570065416E-12 |
| Normal-vs-Obese |
3.93590000000721E-05 |
| Normal-vs-Extreme_Obese |
7.49689998968961E-09 |
| Normal_Weight-vs-Extreme_Weight |
6.001000E-01 |
| Normal_Weight-vs-Obese |
1.562850E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.014600E-01 |
| Extreme_Weight-vs-Obese |
2.790400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.132600E-01 |
| Obese-vs-Extreme_Obese |
2.014300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.502200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.02140000013407E-07 |
| Normal-vs-Age(61-80Yrs) |
5.55111512312578E-16 |
| Normal-vs-Age(81-100Yrs) |
4.378100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.699600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.200700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.593760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.284800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.372200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.600600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.72177852373079E-13 |
| Normal-VS-Type2 PRCC |
1.48614454076323E-12 |
| Normal-VS-KIRP CIMP |
6.605000E-01 |
| Normal-VS-Unclassified PRCC |
3.235200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.954400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.863900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.775600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.694100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.276200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.880040E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.03839999721478E-08 |
| Normal-vs-N1 |
1.224200E-01 |
| Normal-vs-N2 |
2.919700E-02 |
| N0-vs-N1 |
4.006000E-02 |
| N0-vs-N2 |
4.609800E-01 |
| N1-vs-N2 |
7.835200E-01 |
|
|
